Profil
Mr. Eric van Zanten is a Head-External Communications at Avantor, Inc. Mr. van Zanten was previously employed as a Vice President-Investors & Public Relations by Atossa Therapeutics, Inc., an Investor Relations Contact & Head-Communications by Faron Pharmaceuticals Oy, and a Senior Director-Communications by UroGen Pharma Ltd. He received his undergraduate degree from Franklin & Marshall College.
Postes actifs de Eric van Zanten
| Sociétés | Poste | Début |
|---|---|---|
| AVANTOR, INC. | Public Communications Contact | 01/01/2024 |
Anciens postes connus de Eric van Zanten
| Sociétés | Poste | Fin |
|---|---|---|
| ATOSSA THERAPEUTICS, INC. | Investor Relations Contact | 01/01/2024 |
| UROGEN PHARMA LTD. | Public Communications Contact | 01/07/2021 |
| FARON PHARMACEUTICALS OY | Investor Relations Contact | - |
Formation de Eric van Zanten
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Atossa Therapeutics, Inc.
Atossa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics and delivery methods for the treatment of breast cancer & other breast conditions | Health Technology |
Franklin & Marshall College
Franklin & Marshall College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Faron Pharmaceuticals Oy
Faron Pharmaceuticals Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
UroGen Pharma Ltd.
UroGen Pharma Ltd. BiotechnologyHealth Technology Develops therapies for urological pathologies | Health Technology |
Avantor, Inc.
Avantor, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies laboratory equipment and bioscience products | Health Technology |
















